Skip to content

Evaluation Efficacy of Tranexamic acid in decreasing blood loss

Evaluation Efficacy of Tranexamic acid in decreasing blood loss in cesarean delivery

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20140420017365N4
Enrollment
100
Registered
2020-04-27
Start date
2019-09-23
Completion date
Unknown
Last updated
2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood loss after cesarean.

Interventions

Intervention 1: Intervention group:Intravenus Injection of tranexamic acid 1.5or1gram to pateints before the onset of cesarean.it is a fibrinolytic agent that reduce the blood loss in surgery.this am
below 90kg and above 90 kg
before cesarean section in control group.

Sponsors

Oroumia University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Candidate for Elective Singleton Cesarean section Having adequate prenatal care. Complete the form of informed consent Age range 18-45 years

Exclusion criteria

Exclusion criteria: Patients do not accept to participate in the study They have anemia and bleeding diseases or serious medical or surgical diseases Sensitivity to Tranexamic acid Fetal macrosomia Thromboembolism Score(V.T.E. scoring)=3 Placental Abruption , placenta parvia and abnormal placental adherence Uterine myoma more than 5 cm Polyhydramnios Multi-fetus pregnancy Use of Anticoagulant such as enoxaparin or heparin Severe pregnancy complications such as preeclampsia Long-term hospitalization more than 3 days before cesarean section

Design outcomes

Primary

MeasureTime frame
?Blood loss. Timepoint: After cesarean section. Method of measurement: Bleeding volume including suctioned blood volume, weight of all draw sheets changed up to 6 hours after surgery.;Blood transfusion. Timepoint: Blood transfusions and blood products at admission time. Method of measurement: number of transfused blood products.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Nikpour

Oroumia University of Medical Sciences

Maryamnikpour1367@gmail.com0442237077

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026